Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer. Annals of surgical oncology. 2018; 25(11):3396-3403.
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nature communications. 2017; 8:15503.
Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer. Scientific reports. 2016; 6:35603.
Polymorphisms in cancer-related pathway genes and lung cancer. The European respiratory journal. 2016; 48(4):1184-1191.
PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy. Scientific reports. 2016; 6:25952.
A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2015; 26(6):1142-8.
The influence of TP53 mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations. Molecular carcinogenesis. 2015; 54(2):93-101.
A functional polymorphism in CSF1R gene is a novel susceptibility marker for lung cancer among never-smoking females. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2014; 9(11):1647-55.
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy. Lung cancer (Amsterdam, Netherlands). 2013; 82(2):330-9.
Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology (Carlton, Vic.). 2012; 17(4):699-706.
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2010; 5(11):1734-40.